Modular Medical, Inc. MODD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
-6.48
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | — | -$18.8M | — | -$18.2M | $17.1M |
| 2024 | — | -$3.7M | — | — | $8.0M |
| 2024 | — | -$17.5M | — | -$15.7M | $11.5M |
| 2023 | — | -$13.9M | — | -$12.6M | $5.1M |
| 2022 | — | -$18.6M | — | -$10.3M | $8.8M |
| 2021 | — | -$7.4M | — | -$6.0M | -$1.3M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.48 (distress)
- Working capital / assets 0.654
- Retained earnings / assets -4.524
- EBIT / assets -1.017
- Equity / liabilities 10.3
Source: SEC EDGAR filings · CIK 0001074871 · as of 2025-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.